Science Explorer Interactive view Map
Company · Seongnam-si · South Korea

ABL Bio (South Korea)

ablbio.comROR OpenAlex
Research works
36
▲ 740% vs 2013–17
Citations
281
7.8 per fractional work
Top-10% rate
18.7%
record average 16.5%
Open access
53%
world 28%

Not ranked overall: ABL Bio (South Korea) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.06× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.70× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 9.78× its world share, 2 worksImmunology and Micro…Neuroscience: 1.16× its world share, 0 worksNeuroscienceChemistry: 0.40× its world share, 0 worksChemistryComputer Science: 0.05× its world share, 0 worksComputer ScienceEngineering: 0.06× its world share, 0 worksEngineeringMaterials Science: 0.41× its world share, 0 worksMaterials ScienceMathematics: 0.32× its world share, 0 worksMathematicsMedicine: 3.36× its world share, 11 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 9.8×. Every wedge is a field page.

Which keywords describe research at ABL Bio (South Korea)?

By fractional works in all years, weighted toward what it does more of than the world: Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, Cancer Immunotherapy, Cancer and Chemotherapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 35 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 35 words, with their numbers
  1. Glycosylation9▲ 118×3 topics
  2. Monoclonal Antibodies8▲ 146×2 topics
  3. Therapeutic Antibodies8▲ 163×2 topics
  4. Antibody Engineering7▲ 205×1 topic
  5. Fc Receptors7▲ 205×1 topic
  6. Cancer Immunotherapy5▲ 96×2 topics
  7. Cancer4▲ 8.4×8 topics
  8. Chemotherapy4▲ 15×4 topics
  9. Immunotherapy4▲ 16×3 topics
  10. Monoclonal Antibody3▲ 130×2 topics
  11. Tumor Regression3▲ 106×2 topics
  12. Breast Cancer3▲ 32×2 topics
  13. CAR T Cells3▲ 204×1 topic
  14. Chimeric Antigen Receptor3▲ 204×1 topic
  15. HER23▲ 265×1 topic
  16. Trastuzumab3▲ 188×1 topic
  17. Angiogenesis3▲ 19×5 topics
  18. Tumor Microenvironment3▲ 21×3 topics
  19. Targeted Therapy2▲ 26×4 topics
  20. Inflammation2▲ 2.2×4 topics
  21. Immune Checkpoint Blockade2▲ 91×1 topic
  22. PD-1 and PD-L12▲ 91×1 topic
  23. Innate Immunity2▲ 14×2 topics
  24. Dendritic Cells2▲ 39×1 topic
  25. Glycans2▲ 56×1 topic
  26. Immune System2▲ 14×1 topic
  27. Immunity2▲ 13×1 topic
  28. Fibrosis1▲ 20×2 topics
  29. PET Imaging1▲ 16×2 topics
  30. Autoimmunity1▲ 16×2 topics
  31. Pericytes1▲ 67×2 topics
  32. Clinical Trials1▲ 5.1×3 topics
  33. Galectins1▲ 139×1 topic
  34. Immune Regulation1▲ 22×1 topic
  35. Prognostic Factors1▲ 6.7×3 topics

Which research topics does ABL Bio (South Korea) publish most on?

By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, Glycosylation and Glycoproteins Research and HER2/EGFR in Cancer Research.

Monoclonal and Polyclona…4Monoclonal and Polyclonal Antibodies Research: 4 fractional worksCAR-T cell therapy resea…2CAR-T cell therapy research: 2 fractional worksGlycosylation and Glycop…1Glycosylation and Glycoproteins Research: 1 fractional worksHER2/EGFR in Cancer Research: 1 fractional worksCancer Immunotherapy and Biomarkers: 1 fractional worksGalectins and Cancer Bio…1Galectins and Cancer Biology: 1 fractional worksColorectal Cancer Treatments and Studies: 0 fractional worksImmunotherapy and Immune Responses: 0 fractional worksLung Cancer Treatments and Mutations: 0 fractional worksViral Infectious Diseases and Gene Expression in Insects: 0 fractional works
Radiology, Nuclear Medicine and ImagingOncologyMolecular BiologyImmunology1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 4 works
  2. 2 CAR-T cell therapy research Oncology 2 works
  3. 3 Glycosylation and Glycoproteins Research Molecular Biology 1 works
  4. 4 HER2/EGFR in Cancer Research Oncology 1 works
  5. 5 Cancer Immunotherapy and Biomarkers Oncology 1 works
  6. 6 Galectins and Cancer Biology Immunology 1 works
  7. 7 Colorectal Cancer Treatments and Studies Oncology 0 works
  8. 8 Immunotherapy and Immune Responses Immunology 0 works
  9. 9 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
  10. 10 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available53.0%not open47.0%

World: 28% of research is openly available.

with international co-authors24.4%domestic only75.6%

World: 19% is written across borders.

How has ABL Bio (South Korea)'s research output changed?

Output in 2018–2022 was 740% higher than in 2013–2017.

2020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Seongnam-si

All research institutions in Seongnam-si

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.